comparemela.com

Latest Breaking News On - Aktis oncology - Page 1 : comparemela.com

Lilly doubles investment in Indiana site to enhance API manufacturing

The company is expanding its Indiana facility to increase API capacity for diabetes and obesity treatments.

United statesNorth carolinaDavid ricksEli lillyAnexus pharmaceuticalsInnovation districtAktis oncologyPharmaceutical technology

ASCO: J&J s radioligand spurs responses, but 4 deaths mar data

ASCO: J&J s radioligand spurs responses, but 4 deaths mar data
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesBristol myers squibbAmerican society of clinical oncologyFusion pharmaceuticalsEli lillyAmerican societyClinical oncologyPoint biopharmaAktis oncology

Eli Lilly and Aktis enter $1bn partnership to develop anticancer radiopharmaceuticals

Eli Lilly and Aktis enter $1bn partnership to develop anticancer radiopharmaceuticals
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Matthew rodenJacob van naardenEli lillyAktis oncologyVan naardenLilly oncologyPoint biopharma

This up-and-coming cancer treatment could be a $25 billion market opportunity — it s already a hotbed for M&A

Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.

New yorkUnited statesDan lyonsBristol rayzebioAndrew tsaiBristol myers squibbPiper sandler tenthoffJeff jonesGregory renzaJanus henderson lyonsPiper sandlerEli lillyWilliam blairEdward tenthoffMatt phippsFusion pharmaceuticals

Aktis, Lilly ink $1 1B cancer radiopharmaceutical deal

The radiopharmaceutical revolution rolls on as Eli Lilly and Co. builds on its prowess in the space with a deal that could bring Aktis Oncology Inc. $1.1 billion. The two plan to develop radiopharmaceuticals targeting cancer. Privately held Aktis also is getting $60 million in cash up front along with an equity investment. The big money would come from preclinical, clinical, regulatory, commercial milestones and tiered royalties. Lilly will select the targets.

Eli lillyAktis oncology incAktis oncology

vimarsana © 2020. All Rights Reserved.